Self-assembly of human latexin into amyloid-like oligomers

BMC Structural Biology

Volumn 7, Issue , 2007, Pages

  Pallarés, Irantzu ^a   Berenguer, Clara ^a   Avilés, Francesc X ^a   Vendrell, Josep ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 4 TOLUIDINYLNAPHTHALENE 6 SULFONATE; AMYLOID; CARBOXYPEPTIDASE A; CONGO RED; CYSTATIN C; DYE; OLIGOMER; PROTEIN LATEXIN; THIOFLAVINE; TRYPTOPHAN; UNCLASSIFIED DRUG; ANTIGEN; BIOPOLYMER; PC3.1 ANTIGEN;

ALPHA HELIX; ARTICLE; FIBER; FLUORESCENCE; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; ULTRAVIOLET RADIATION; CHEMISTRY; CIRCULAR DICHROISM; HUMAN; ULTRAVIOLET SPECTROPHOTOMETRY;

AMYLOID; ANTIGENS; BIOPOLYMERS; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; PROTEIN CONFORMATION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 38649120047     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-7-75     Document Type: Article

References (43)

1. Amyloidosis. SY Tan MB Pepys, Histopathology 1994 25 5 403 414 10.1111/j.1365-2559.1994.tb00001.x 7868080
2. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. M Sunde CC Blake, Q Rev Biophys 1998 31 1 1 39 10.1017/S0033583598003400 9717197
3. Human lysozyme gene mutations cause hereditary systemic amyloidosis. MB Pepys PN Hawkins DR Booth DM Vigushin GA Tennent AK Soutar N Totty O Nguyen CC Blake CJ Terry, Nature 1993 362 6420 553 557 10.1038/362553a0 8464497
4. 'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis. RF Harrison PN Hawkins WR Roche RF MacMahon SG Hubscher JA Buckels, Gut 1996 38 1 151 152 8566845 10.1136/gut.38.1.151
5. Protein folding and misfolding. CM Dobson, Nature 2003 426 6968 884 890 10.1038/nature02261 14685248
6. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. KW Lee SH Lee H Kim JS Song SD Yang SG Paik PL Han, J Neurosci Res 2004 76 4 572 580 10.1002/jnr.20127 15114629
7. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Y Gong L Chang KL Viola PN Lacor MP Lambert CE Finch GA Krafft WL Klein, Proc Natl Acad Sci U S A 2003 100 18 10417 10422 12925731 10.1073/pnas.1834302100
8. Only amyloidogenic intermediates of transthyretin induce apoptosis. K Andersson A Olofsson EH Nielsen SE Svehag E Lundgren, Biochem Biophys Res Commun 2002 294 2 309 314 10.1016/S0006-291X(02)00465-5 12051711
9. Self-assembly of Abeta(1-42) into globular neurotoxins. BA Chromy RJ Nowak MP Lambert KL Viola L Chang PT Velasco BW Jones SJ Fernandez PN Lacor P Horowitz CE Finch GA Krafft WL Klein, Biochemistry 2003 42 44 12749 12760 10.1021/bi030029q 14596589
10. An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1. A Aagaard P Listwan N Cowieson T Huber T Ravasi CA Wells JU Flanagan S Kellie DA Hume B Kobe JL Martin, Structure 2005 13 2 309 317 10.1016/j.str.2004.12.013 15698574
11. Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. I Pallares R Bonet R Garcia-Castellanos S Ventura FX Aviles J Vendrell FX Gomis-Ruth, Proc Natl Acad Sci U S A 2005 102 11 3978 3983 15738388 10.1073/pnas.0500678102
12. The structural basis of protein folding and its links with human disease. CM Dobson, Philos Trans R Soc Lond B Biol Sci 2001 356 1406 133 145 11260793 10.1098/rstb.2000.0758
13. 3D domain-swapped human cystatin C with amyloidlike intermolecular beta-sheets. R Janowski M Kozak M Abrahamson A Grubb M Jaskolski, Proteins 2005 61 3 570 578 10.1002/prot.20633 16170782
14. Essential role of proline isomerization in stefin B tetramer formation. S Jenko Kokalj G Guncar I Stern G Morgan S Rabzelj M Kenig RA Staniforth JP Waltho E Zerovnik D Turk, J Mol Biol 2007 366 5 1569 1579 10.1016/j.jmb.2006.12. 025 17217964
15. CDPro [http://lamar.colostate.edu/∼sreeram/CDPro].
16. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. H LeVine 3rd, Protein Sci 1993 2 3 404 410 8453378
17. Kinetic theory of fibrillogenesis of amyloid beta-protein. A Lomakin DB Teplow DA Kirschner GB Benedek, Proc Natl Acad Sci U S A 1997 94 15 7942 7947 9223292 10.1073/pnas.94.15.7942
18. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. WE Klunk JW Pettegrew DJ Abraham, J Histochem Cytochem 1989 37 8 1273 1281 2666510
19. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. AM Fernandez-Escamilla F Rousseau J Schymkowitz L Serrano, Nat Biotechnol 2004 22 1302 11306 10.1038/nbt1012 15361882
20. Prediction of "aggregation-prone" and "aggregation- susceptible" regions in proteins associated with neurodegenerative diseases. AP Pawar KF Dubay J Zurdo F Chiti M Vendruscolo CM Dobson, J Mol Biol 2005 350 2 379 392 10.1016/j.jmb.2005.04.016 15925383
21. Prediction of "hot spots" of aggregation in disease-linked polypeptides. N de Groot I Pallares F Aviles J Vendrell S Ventura, BMC Structural Biology 2005 5 1 18 16197548 10.1186/1472-6807-5-18
22. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides. O Conchillo-Sole NS de Groot FX Aviles J Vendrell X Daura S Ventura, BMC Bioinformatics 2007 8 65 17324296 10.1186/1471-2105-8-65
23. The environmental dependency of protein folding best explains prion and amyloid diseases. JW Kelly, Proc Natl Acad Sci U S A 1998 95 3 930 932 9448261 10.1073/pnas.95.3.930
24. Conformational constraints for amyloid fibrillation: the importance of being unfolded. VN Uversky AL Fink, Biochim Biophys Acta 2004 1698 131 1153 15134647
25. Mutational analysis of the propensity for amyloid formation by a globular protein. F Chiti N Taddei M Bucciantini P White G Ramponi CM Dobson, Embo J 2000 19 7 1441 1449 10747012 10.1093/emboj/19.7.1441
26. Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. S Ventura E Lacroix L Serrano, J Mol Biol 2002 322 1147 11458 10.1016/S0022-2836(02)00783-0 12367534
27. Amyloid fibril formation by a partially structured intermediate state of alpha-chymotrypsin. I Pallares J Vendrell FX Aviles S Ventura, J Mol Biol 2004 342 321 3231 10.1016/j.jmb.2004.06.089 15313627
28. Interaction of human stefin B in the prefibrillar oligomeric form with membranes. Correlation with cellular toxicity. G Anderluh I Gutierrez-Aguirre S Rabzelj S Ceru N Kopitar-Jerala P Macek V Turk E Zerovnik, Febs J 2005 272 12 3042 3051 10.1111/j.1742-4658.2005.04717.x 15955063
29. Prevention of amyloid fibril formation of amyloidogenic chicken cystatin by site-specific glycosylation in yeast. J He Y Song N Ueyama A Saito H Azakami A Kato, Protein Sci 2006 15 2 213 222 10.1110/ps.051753306 16434741
30. Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. M Fandrich V Forge K Buder M Kittler CM Dobson S Diekmann, Proc Natl Acad Sci U S A 2003 100 26 15463 15468 14665689 10.1073/pnas.0303758100
31. Folding-related dimerization of human cystatin C. I Ekiel M Abrahamson, J Biol Chem 1996 271 3 1314 1321 10.1074/jbc.271.3.1314 8576118
32. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. R Janowski M Kozak E Jankowska Z Grzonka A Grubb M Abrahamson M Jaskolski, Nat Struct Biol 2001 8 4 316 320 10.1038/86188 11276250
33. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. M Wahlbom X Wang V Lindstrom E Carlemalm M Jaskolski A Grubb, J Biol Chem 2007 282 25 18318 18326 10.1074/jbc.M611368200 17470433
34. Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. M Nilsson X Wang S Rodziewicz-Motowidlo R Janowski V Lindstrom P Onnerfjord G Westermark Z Grzonka M Jaskolski A Grubb, J Biol Chem 2004 279 23 24236 24245 10.1074/jbc.M402621200 15028721
35. Amyloid-like fibril formation in an all beta-barrel protein involves the formation of partially structured intermediate(s). S Srisailam HM Wang TK Kumar D Rajalingam V Sivaraja HS Sheu YC Chang C Yu, J Biol Chem 2002 277 21 19027 19036 10.1074/jbc.M110762200 11877422
36. Structure of the cross-beta spine of amyloid-like fibrils. R Nelson MR Sawaya M Balbirnie AO Madsen C Riekel R Grothe D Eisenberg, Nature 2005 435 7043 773 778 15944695 10.1038/nature03680
37. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. MR Sawaya S Sambashivan R Nelson MI Ivanova SA Sievers MI Apostol MJ Thompson M Balbirnie JJ Wiltzius HT McFarlane AO Madsen C Riekel D Eisenberg, Nature 2007 447 7143 453 457 10.1038/nature05695 17468747
38. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. WL Klein WB Stine Jr. DB Teplow, Neurobiol Aging 2004 25 5 569 580 10.1016/j.neurobiolaging.2004.02.010 15172732
39. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. B Caughey PT Lansbury, Annu Rev Neurosci 2003 26 267 298 10.1146/annurev.neuro.26.010302. 081142 12704221
40. Urea modulation of beta-amyloid fibril growth: experimental studies and kinetic models. JR Kim A Muresan KY Lee RM Murphy, Protein Sci 2004 13 11 2888 2898 10.1110/ps.04847404 15459334
41. AGGRESCAN. http://bioinf.uab.es/aggrescan/
42. TANGO. http://tango.embl.de/
43. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. M Balbirnie R Grothe DS Eisenberg, Proc Natl Acad Sci U S A 2001 98 5 2375 2380 11226247 10.1073/pnas.041617698